16-21984571-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001363519.1(PDZD9):āc.491A>Gā(p.Tyr164Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,572,988 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001363519.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDZD9 | NM_001363519.1 | c.491A>G | p.Tyr164Cys | missense_variant | 4/4 | ENST00000424898.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDZD9 | ENST00000424898.3 | c.491A>G | p.Tyr164Cys | missense_variant | 4/4 | 5 | NM_001363519.1 | P1 | |
PDZD9 | ENST00000523914.5 | c.*268A>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ||||
PDZD9 | ENST00000537222.6 | c.311A>G | p.Tyr104Cys | missense_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152224Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00000424 AC: 1AN: 235808Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 127318
GnomAD4 exome AF: 0.0000155 AC: 22AN: 1420646Hom.: 0 Cov.: 31 AF XY: 0.0000129 AC XY: 9AN XY: 699286
GnomAD4 genome AF: 0.000112 AC: 17AN: 152342Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.311A>G (p.Y104C) alteration is located in exon 3 (coding exon 3) of the PDZD9 gene. This alteration results from a A to G substitution at nucleotide position 311, causing the tyrosine (Y) at amino acid position 104 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at